In the US, VPRIV (velaglucerase alfa systemic) is a member of the drug class lysosomal enzymes and is used to treat Gaucher Disease.
US matches:
- VPRIV
Ingredient matches for VPRIV
Velaglucerase Alfa
Velaglucerase alfa is reported as an ingredient of VPRIV in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment